Enzyme-pris

Enzyme (MLN) is a decentralized finance (DeFi) project reshaping the landscape of asset management. Built on Ethereum, Enzyme empowers both individuals and institutions to seamlessly create, manage, and have a stake in decentralized funds. By leveraging the power of blockchain technology, Enzyme provides enhanced security, transparency, and accessibility to the world of asset management.

What is Enzyme

Enzyme is an on-chain, decentralized asset management protocol that operates on the Ethereum blockchain. It is designed to offer asset managers and traders a seamless and efficient platform for interacting and managing portfolios. By harnessing the capabilities of blockchain technology and smart contracts, Enzyme automates key functions such as trading, reporting, and settlement.

The decentralized protocol ensures that asset management activities are conducted directly on the blockchain, eliminating the need for intermediaries. This enhances transparency, reduces costs and entry barriers, and increases efficiency in portfolio management. Asset managers can create and customize strategies while traders gain access to a wide range of portfolio options.

The Enzyme team

Enzyme was co-founded by Mona El Isa and Reto Trinkler, both of whom have extensive experience in the financial and blockchain industries. Mona El Isa, a former Goldman Sachs trader, recognized the need for a decentralized asset management platform that could democratize trading opportunities and eliminate traditional intermediaries and high barriers to entry. Reto Trinkler, an entrepreneur and blockchain expert, shared her vision. Together, they created Enzyme, assembling a team of talented developers and industry professionals.

How does Enzyme work

Enzyme leverages the power of smart contracts to provide a transparent and secure platform for asset management. Enzyme’s web portal includes a unique system that allows users to have a stake in funds or portfolios created by other Enzyme members.

The protocol is structured into two primary layers: the fund layer and the infrastructure layer. In the fund layer, users launch and manage funds that others can participate in. Central to this layer is "The Hub," which equips users with essential tools for setting up and monitoring individual funds.

The infrastructure layer, on the other hand, oversees the execution of infrastructure contracts. This includes an "adapter" contract that links assets to price feeds and a "price source" contract that interacts with price feeds to provide accurate rates to platform users.

Enzyme’s native token: MLN

MLN is the native token of the Enzyme ecosystem. It serves multiple purposes within the platform, including governance, fee payment, and staking rewards. MLN holders have the power to vote on proposals and make decisions that shape the future development of the Enzyme protocol. Furthermore, fees generated from fund activities, such as management and performance fees, are paid in MLN.

MLN tokenomics

The total supply of MLN tokens is fixed at 1.25 million. The distribution of MLN tokens occurred through various channels, including a token sale, community initiatives, and partnerships. The token sale aimed to raise funds for the development of the Enzyme protocol, ensuring its sustainability and growth. A portion of the MLN tokens was allocated to incentivize and reward early adopters, developers, and ecosystem participants.

MLN use cases

Within the Enzyme community, MLN can be used for governance purposes, allowing token holders to participate in decision-making processes, vote on proposals, and influence the direction of the protocol.

MLN is also used for fee payments associated with various fund activities, including management and performance fees. By utilizing MLN for fee payments, Enzyme establishes a sustainable revenue model for the protocol.

Distribution of MLN

MLN is distributed as follows:

• 40 percent was sold to public token sale participants.
• 8 percent was designated for the Melonport AG.
• 14.7 percent was reserved as developer incentives.
• 12 percent was allotted to the founders, advisors, and partners of the project.
• 25.3 percent was unallocated and subsequently burned.

Enzyme and the future of asset management

Enzyme is revolutionizing the asset management industry by leveraging blockchain technology to create a decentralized, transparent, and efficient platform. The Enzyme team, led by Mona El Isa and Reto Trinkler, has developed a robust protocol that allows individuals and institutions to create and manage decentralized funds.

The MLN token serves as the backbone of the Enzyme ecosystem, providing governance rights, fee payment capabilities, and staking rewards. With its innovative approach to asset management and a strong team driving its development, Enzyme has the potential to reshape the financial landscape and empower a new generation of traders.